Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 20 January 2004
Vol. 2004, Issue 216, p. re2
[DOI: 10.1126/stke.2162004re2]

REVIEWS

G Proteins in Cancer: The Prostate Cancer Paradigm

Yehia Daaka*

Department of Surgery and Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

Abstract: Signal transduction research investigating mechanisms of androgen-independent prostate cancer cell proliferation has historically focused on the role of androgen and peptide growth factor receptors. More recent work has raised the idea that intracellular signaling mechanisms triggered by extracellular hormonal factors acting through heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) can also mediate and sustain this pathologic process. Prostate cancer patients with advanced disease express elevated levels of GPCRs and GPCR ligands, suggesting that the GPCR system is activated in the cancerous gland and may contribute to tumor growth. Importantly, inhibition of G protein signaling attenuates prostate cancer cell growth in animal models. The nature of intracellular signaling pathways mediating mitogenic effects of GPCRs in prostate cancer is poorly defined, although the G protein-dependent activation of the Ras-to-mitogen-activated protein kinase pathway has emerged as a critical regulatory event. Activated GPCRs may also exert their mitogenic effects in the prostate by activating the androgen receptor.

Contact information. DUMC 2607, Duke University Medical Center, Durham, NC 27710, USA. Telephone, 919-684-8440; fax, 919-684-9990; e-mail, daaka001{at}mc.duke.edu

Citation: Y. Daaka, G Proteins in Cancer: The Prostate Cancer Paradigm. Sci. STKE 2004, re2 (2004).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
G Protein-Coupled Receptor-Mediated Activation of p110{beta} by G{beta}{gamma} Is Required for Cellular Transformation and Invasiveness.
H. A. Dbouk, O. Vadas, A. Shymanets, J. E. Burke, R. S. Salamon, B. D. Khalil, M. O. Barrett, G. L. Waldo, C. Surve, C. Hsueh, et al. (2012)
Science Signaling 5, ra89
   Abstract »    Full Text »    PDF »
Dissection of Aberrant GPCR Signaling in Tumorigenesis - A Systems Biology Approach.
J. Wu, N. Xie, X. Zhao, E. C. Nice, and C. Huang (2012)
Cancer Genomics Proteomics 9, 37-50
   Abstract »    Full Text »    PDF »
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer.
P. Gazzerro, M. C. Proto, G. Gangemi, A. M. Malfitano, E. Ciaglia, S. Pisanti, A. Santoro, C. Laezza, and M. Bifulco (2012)
Pharmacol. Rev. 64, 102-146
   Abstract »    Full Text »    PDF »
Disease-associated GPR56 Mutations Cause Bilateral Frontoparietal Polymicrogyria via Multiple Mechanisms.
N.-Y. Chiang, C.-C. Hsiao, Y.-S. Huang, H.-Y. Chen, I.-J. Hsieh, G.-W. Chang, and H.-H. Lin (2011)
J. Biol. Chem. 286, 14215-14225
   Abstract »    Full Text »    PDF »
G{beta}{gamma} Signaling Promotes Breast Cancer Cell Migration and Invasion.
J. K. Kirui, Y. Xie, D. W. Wolff, H. Jiang, P. W. Abel, and Y. Tu (2010)
J. Pharmacol. Exp. Ther. 333, 393-403
   Abstract »    Full Text »    PDF »
Critical Role of G{alpha}12 and G{alpha}13 for Human Small Cell Lung Cancer Cell Proliferation In vitro and Tumor Growth In vivo.
M. Grzelinski, O. Pinkenburg, T. Buch, M. Gold, S. Stohr, H. Kalwa, T. Gudermann, and A. Aigner (2010)
Clin. Cancer Res. 16, 1402-1415
   Abstract »    Full Text »    PDF »
Identification of {beta}Arrestin2 as a corepressor of androgen receptor signaling in prostate cancer.
V. Lakshmikanthan, L. Zou, J. I. Kim, A. Michal, Z. Nie, N. C. Messias, J. L. Benovic, and Y. Daaka (2009)
PNAS 106, 9379-9384
   Abstract »    Full Text »    PDF »
The Glutamatergic System Expression in Human PC-3 and LNCaP Prostate Cancer Cells.
N. PISSIMISSIS, E. PAPAGEORGIOU, P. LEMBESSIS, A. ARMAKOLAS, and M. KOUTSILIERIS (2009)
Anticancer Res 29, 371-377
   Abstract »    Full Text »    PDF »
2,2-Bis(4-Chlorophenyl)-1,1-Dichloroethylene Stimulates Androgen Independence in Prostate Cancer Cells through Combinatorial Activation of Mutant Androgen Receptor and Mitogen-Activated Protein Kinase Pathways.
S. Shah, J. K. Hess-Wilson, S. Webb, H. Daly, S. Godoy-Tundidor, J. Kim, J. Boldison, Y. Daaka, and K. E. Knudsen (2008)
Mol. Cancer Res. 6, 1507-1520
   Abstract »    Full Text »    PDF »
Vasoactive Intestinal Peptide Transactivates the Androgen Receptor through a Protein Kinase A-Dependent Extracellular Signal-Regulated Kinase Pathway in Prostate Cancer LNCaP Cells.
Y. Xie, D. W. Wolff, M.-F. Lin, and Y. Tu (2007)
Mol. Pharmacol. 72, 73-85
   Abstract »    Full Text »    PDF »
Ligand Binding to the Androgen Receptor Induces Conformational Changes That Regulate Phosphatase Interactions.
C.-S. Yang, H.-W. Xin, J. B. Kelley, A. Spencer, D. L. Brautigan, and B. M. Paschal (2007)
Mol. Cell. Biol. 27, 3390-3404
   Abstract »    Full Text »    PDF »
Differential targeting of Gbetagamma-subunit signaling with small molecules..
T. M. Bonacci, J. L. Mathews, C. Yuan, D. M. Lehmann, S. Malik, D. Wu, J. L. Font, J. M. Bidlack, and A. V. Smrcka (2006)
Science 312, 443-446
   Abstract »    Full Text »    PDF »
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy.
M. F. McCarty (2004)
Integr Cancer Ther 3, 349-380
   Abstract »    PDF »
Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases.
Y. Hahn, T. K. Bera, K. Gehlhaus, I. R. Kirsch, I. H. Pastan, and B. Lee (2004)
PNAS 101, 13257-13261
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882